Yogen Saunthararajah
Yogen Saunthararajah
Cleveland Clinic, Case Western Reserve University
Verified email at
Cited by
Cited by
Effect of hydroxyurea on mortality and morbidity in adult sickle cell anemia: risks and benefits up to 9 years of treatment
MH Steinberg, F Barton, O Castro, CH Pegelow, SK Ballas, A Kutlar, ...
Jama 289 (13), 1645-1651, 2003
Aberrant DNA methylation is a dominant mechanism in MDS progression to AML
Y Jiang, A Dunbar, LP Gondek, S Mohan, M Rataul, C O'Keefe, ...
Blood, The Journal of the American Society of Hematology 113 (6), 1315-1325, 2009
Inherited and somatic defects in DDX41 in myeloid neoplasms
C Polprasert, I Schulze, MA Sekeres, H Makishima, B Przychodzen, ...
Cancer cell 27 (5), 658-670, 2015
Dynamics of clonal evolution in myelodysplastic syndromes
H Makishima, T Yoshizato, K Yoshida, MA Sekeres, T Radivoyevitch, ...
Nature genetics 49 (2), 204-212, 2017
HLA-DR15 (DR2) is overrepresented in myelodysplastic syndrome and aplastic anemia and predicts a response to immunosuppression in myelodysplastic syndrome
Y Saunthararajah, R Nakamura, JM Nam, J Robyn, F Loberiza, ...
Blood, The Journal of the American Society of Hematology 100 (5), 1570-1574, 2002
Impact of molecular mutations on treatment response to DNMT inhibitors in myelodysplasia and related neoplasms
F Traina, V Visconte, P Elson, A Tabarroki, AM Jankowska, E Hasrouni, ...
Leukemia 28 (1), 78-87, 2014
Effects of 5-aza-2′-deoxycytidine on fetal hemoglobin levels, red cell adhesion, and hematopoietic differentiation in patients with sickle cell disease
Y Saunthararajah, CA Hillery, D Lavelle, R Molokie, L Dorn, L Bressler, ...
Blood 102 (12), 3865-3870, 2003
Antithymocyte globulin for treatment of the bone marrow failure associated with myelodysplastic syndromes
JJ Molldrem, E Leifer, E Bahceci, Y Saunthararajah, M Rivera, C Dunbar, ...
Annals of internal medicine 137 (3), 156-163, 2002
Inhibitors of histone deacetylase relieve ETO-mediated repression and induce differentiation of AML1-ETO leukemia cells
J Wang, Y Saunthararajah, RL Redner, JM Liu
Cancer research 59 (12), 2766-2769, 1999
Somatic SETBP1 mutations in myeloid malignancies
H Makishima, K Yoshida, N Nguyen, B Przychodzen, M Sanada, Y Okuno, ...
Nature genetics 45 (8), 942-946, 2013
Modification of hematopoietic stem cell fate by 5aza 2′ deoxycytidine and trichostatin A
M Milhem, N Mahmud, D Lavelle, H Araki, J DeSimone, Y Saunthararajah, ...
Blood 103 (11), 4102-4110, 2004
A simple method to predict response to immunosuppressive therapy in patients with myelodysplastic syndrome
Y Saunthararajah, R Nakamura, R Wesley, QJ Wang, AJ Barrett
Blood 102 (8), 3025-3027, 2003
Myelodysplastic syndrome and aplastic anemia: distinct entities or diseases linked by a common pathophysiology?
J Barrett, Y Saunthararajah, J Molldrem
Seminars in hematology 37 (1), 15-29, 2000
Efficacy and safety of the Gardos channel blocker, senicapoc (ICA-17043), in patients with sickle cell anemia
KI Ataga, WR Smith, LM De Castro, P Swerdlow, Y Saunthararajah, ...
Blood, The Journal of the American Society of Hematology 111 (8), 3991-3997, 2008
EVI1 induces myelodysplastic syndrome in mice
S Buonamici, D Li, Y Chi, R Zhao, X Wang, L Brace, H Ni, ...
The Journal of clinical investigation 114 (5), 713-719, 2004
Novel homo-and hemizygous mutations in EZH2 in myeloid malignancies
H Makishima, AM Jankowska, RV Tiu, H Szpurka, Y Sugimoto, Z Hu, ...
Leukemia 24 (10), 1799-1804, 2010
SF3B1 haploinsufficiency leads to formation of ring sideroblasts in myelodysplastic syndromes
V Visconte, HJ Rogers, J Singh, J Barnard, M Bupathi, F Traina, ...
Blood, The Journal of the American Society of Hematology 120 (16), 3173-3186, 2012
Increased frequency of HLA-DR2 in patients with paroxysmal nocturnal hemoglobinuria and the PNH/aplastic anemia syndrome
JP Maciejewski, D Follmann, R Nakamura, Y Saunthararajah, CE Rivera, ...
Blood, The Journal of the American Society of Hematology 98 (13), 3513-3519, 2001
Patient-reported outcomes: descriptors of nociceptive and neuropathic pain and barriers to effective pain management in adult outpatients with sickle cell disease
DJ Wilkie, R Molokie, D Boyd-Seal, ML Suarez, YO Kim, S Zong, H Wittert, ...
Journal of the National Medical Association 102 (1), 18-27, 2010
Multiple mechanisms deregulate EZH2 and histone H3 lysine 27 epigenetic changes in myeloid malignancies
SN Khan, AM Jankowska, R Mahfouz, AJ Dunbar, Y Sugimoto, N Hosono, ...
Leukemia 27 (6), 1301-1309, 2013
The system can't perform the operation now. Try again later.
Articles 1–20